Mahina Mele Farms, LLC Recalls Macadamia Nut Products Due To Possible Health Risk

Mahina Mele Farms, LLC is recalling the following products after FDA testing found Salmonella in macadamia nuts. Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.
Read The Complete Story!

Fresh Express Announces Precautionary Recall of a Limited Quantity of 12 oz. Baby Spinach Due to Possible Allergen Exposure

Fresh Express Incorporated is voluntarily issuing a precautionary recall of 350 cases of 12 oz. Fresh Express Baby Spinach with a Product Code of G010A17A and Use-By Date of January 24 due to a possible exposure to a tree nut allergen (almond). Fresh Express representatives are already coordinating with stores to remove the recalled product from retail stores where distributed, primarily in Eastern and Southeastern states.

Heritage International (USA) Inc, Voluntarily Recalls One Lot of Raw Cashew Pieces Because of Possible Salmonella Health Risk

Heritage International (USA) Inc. of Compton, CA is voluntarily recalling one lot of Trader Joe’s Raw Cashew Pieces with the following code “BEST BEFORE 07.17.2016TF4” because of potential contamination with Salmonella. Salmonella is an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

FDA outlines cybersecurity recommendations for medical device manufacturers

The U.S. Food and Drug Administration today issued a draft guidance outlining important steps medical device manufacturers should take to continually address cybersecurity risks to keep patients safe and better protect the public health. The draft guidance details the agency’s recommendations for monitoring, identifying and addressing cybersecurity vulnerabilities in medical devices once they have entered the market. The draft guidance is part of the FDA’s ongoing efforts to ensure the safety and effectiveness of medical devices, at all stages in their lifecycle, in the face of potential cyber threats.

FDA clears Olympus TJF-Q180V duodenoscope with design modifications intended to reduce infection risk

The U.S. Food and Drug Administration today cleared the Olympus TJF-Q180V duodenoscope with modifications to the device’s design and labeling intended to help reduce the risk of bacterial infections. Olympus will voluntarily recall its original model currently being used in health care facilities and make the needed repair as quickly as possible.